Are you Dr. Hayes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 92 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
D1230 Dana-Farber Cancer Institute
Boston, MA 02115Phone+1 617-632-2311Fax+1 617-632-2165
Summary
- Dr. Julia Hayes, MD is an oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and New York. She is affiliated with Dana-Farber Cancer Institute and Salem Hospital.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2007
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- Harvard Medical SchoolClass of 2001
Certifications & Licensure
- MA State Medical License 2004 - 2026
- NY State Medical License 2004 - 2005
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 14 citationsDecision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trialDonna L. Berry, Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Niya Xiong
Urologic Oncology. 2021-08-01 - 34 citationsDecision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized TrialDonna L. Berry, Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Christopher P. Filson
The Journal of Urology. 2018-01-01 - 30 citationsImpact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of deathToni K. Choueiri, Ming-Hui Chen, Anthony V. D'Amico, Leon Sun, Paul L. Nguyen
Cancer. 2010-04-15
Press Mentions
- Observation Is Safe, Cost-Saving in Low-Risk Prostate Cancer, Study SuggestsFebruary 10th, 2016
- Low-Risk Prostate Cancer, Observation Safe and Cost-EffectiveFebruary 10th, 2016
Professional Memberships
- Member